Retractable Technologies Inc(RVP) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
October 7 at 4:00 PM ET (Korea 10/8 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.12 | Insider Own | 59.23% | Shs Outstand | 29.9M | Perf Week | -0.03% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 12.2M | Perf Month | -1.31% |
| Enterprise Value | -0.02B | PEG | - | EPS next Q | - | Inst Own | 8.81% | Short Float | 0.51% | Perf Quarter | -0.86% |
| Income | -0.00B | P/S | 0.61 | EPS this Y | - | Inst Trans | 3.92% | Short Ratio | 2.29 | Perf Half Y | 1.54% |
| Sales | 0.03B | P/B | 0.28 | EPS next 5Y | - | ROA | -2.33% | Short Interest | 0.06M | Perf YTD | -10.53% |
| Book/sh | 2.43 | P/C | 0.52 | EPS past 3/5Y | - | ROE | -4.52% | 52W High | -39.4% ($1.14) | Perf Year | -26.63% |
| Cash/sh | 1.33 | P/FCF | - | Sales past 3/5Y | -26.1% -14.11% | ROIC | -4.61% | 52W Low | 14.81% ($0.60) | Perf 3Y | -42.34% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 59.85% | Gross Margin | 1.16% | Volatility(W/M) | 3.53% 3.46% | Perf 5Y | -93.06% |
| Dividend TTM | - | EV/Sales | -0.53 | Sales Y/Y TTM | -11.16% | Oper. Margin | -64.09% | ATR (14) | 0.02 | Perf 10Y | -73.22% |
| Dividend Ex-Date | - | Quick Ratio | 3.74 | EPS Q/Q | 2029.17% | Profit Margin | -10.62% | RSI (14) | 46.79 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.93 | Sales Q/Q | -31.07% | SMA20 | -0.39% ($0.69) | Beta | 1.3 | Target Price | - |
| Payout | - | Debt/Eq | 0.01 | Earnings | - | SMA50 | -0.93% ($0.7) | Rel Volume | 0.98 | Prev Close | $0.69 |
| Employees | 201 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -0.89% ($0.7) | Avg Volume(3M) | 0.03M | Price | $0.69 |
| IPO | 2001/5/4 | Option/Short | Yes/Yes | Trades | 39 | Volume | 26,707 | Change | -0.01% |
💉 Retractable Technologies is a US medical device company that manufactures safety syringes and blood collection devices with needles that automatically retract into the barrel. Its flagship products, VanishPoint® and EasyPoint®, are designed to prevent needlestick injuries among healthcare workers. With rapidly growing international sales, the company has expanded its annual revenue into double-digit millions, making it a small-cap medical device stock to watch.
Over the past 1 year, on the lower side
39% below its 1-year high.
Traded about as much as usual That is 98% of its average volume.
RVP has a sound balance sheet but weak earning power
Of every $100 in sales, $64.09 is lost.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $61. Peers typically go for $270. Compared with its own 2-year average, it is 215% pricier now.
Tap to view numbers
Not enough quarters to judge yet
Only 1 quarter(s) reported, so no grade yet.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -93.1%. The S&P 500 did +77% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 8.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
VTI Vanguard Morningstar Total Stock Market ETF <0.01% 
VXF Vanguard Extended Market Index ETF <0.01% It ranks #45 of 51 in the industry
Based on market cap of $21M.
NEPH#43 Nephros Inc $35M PER 20.4 
MLSS#44 Milestone Scientific Inc $34M PER - RVP#45 Retractable Technologies Inc $21M PER - 
BNGO#46 Bionano Genomics Inc $17M PER - 
FEMY#47 Femasys Inc $17M PER - 
FAQ
What kind of company is RVP?
RVP belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of RVP?
The market cap of RVP is approximately $21M, ranking 5,259 within its sector.
What is the 52-week high and low for RVP?
RVP has recorded a 52-week high of $1.14 and a low of $0.60.
